XML 79 R35.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-based Compensation (Tables)
6 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
On May 18, 2019, the Company granted RSUs under the 2020/2021 LTIP with a grant date fair value of $18.15 per share that vest as follows (amounts in thousands):
 
Shares
May 18, 2020
66

May 18, 2021
140

May 18, 2022
142

Total RSUs granted (1)
348

 __________________
(1) RSUs granted include time-based and performance-based RSUs. Therefore, the granted performance-based RSUs included above are an estimate based upon current performance expectations. The final number of RSUs granted depends on the achievement of performance metrics.
The following is the vesting schedule of RSUs under each respective LTIP, that vested during the six months ended September 30, 2019 (shares in thousands):
 
 
2019/2020
 
2018/2019
 
2017/2018
Time-based award vested
 
53

 
58

 
156

Performance-based award vested
 

 

 


RSU activity, including performance-based and time-based LTIP activity, for the six months ended September 30, 2019 is as follows (amounts in thousands except fair value):
 
Shares
 
Weighted-
average
Fair Value on
Grant Date
Non-vested RSUs at March 31, 2019
1,415

 
$
15.19

Granted
409

 
18.39

Vested
(365
)
 
10.87

Forfeited
(10
)
 
15.73

Non-vested RSUs at September 30, 2019
1,449

 
$
17.18

Schedule of the compensation expense (recovery) associated with stock-based compensation
The expense associated with stock-based compensation for the three months ended September 30, 2019 and 2018 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands):
 
Three Months Ended September 30, 2019
 
Three Months Ended September 30, 2018
 
Stock 
Options
 
RSUs
 
LTIPs
 
Stock 
Options
 
RSUs
 
LTIPs
Cost of sales
$

 
$
495

 
$
487

 
$

 
$
351

 
$
335

Selling, general and administrative expenses

 
2,175

 
872

 

 
2,807

 
840

Research and development

 
35

 
82

 

 
17

 
67

Total
$

 
$
2,705

 
$
1,441

 
$

 
$
3,175

 
$
1,242


The expense associated with stock-based compensation for the six months ended September 30, 2019 and 2018 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands):
 
Six Months Ended September 30, 2019
 
Six Months Ended September 30, 2018
 
Stock 
Options
 
Restricted 
Stock
 
LTIPs
 
Stock 
Options
 
Restricted 
Stock
 
LTIPs
Cost of sales
$

 
$
985

 
$
871

 
$

 
$
701

 
$
574

Selling, general and administrative expenses

 
3,179

 
1,603

 

 
5,688

 
1,361

Research and development

 
70

 
163

 

 
32

 
121

Total
$

 
$
4,234

 
$
2,637

 
$

 
$
6,421

 
$
2,056